Company Filing History:
Years Active: 2014
Title: Innovations of Craig A Press in Axonal Degeneration Research
Introduction
Craig A Press is an accomplished inventor based in St. Louis, MO (US). He has made significant contributions to the field of neuroscience, particularly in the area of axonal degeneration. His innovative work focuses on methods to inhibit this degeneration, which is crucial for developing treatments for various neurological conditions.
Latest Patents
Craig A Press holds a patent titled "Methods and compositions for inhibition of axonal degeneration by modulation of the DLK/JNK pathway." This patent discloses methods for reducing Wallerian degeneration by inhibiting the expression or activity of mixed lineage kinases, such as dual leucine-zipper-bearing kinase (DLK), and c-Jun N-terminal kinase (JNK). The patent also outlines methods for screening candidate compounds for DLK inhibition activity, which involves neuronal cultures and axon degeneration-triggering agents.
Career Highlights
Craig A Press is affiliated with Washington University, where he conducts his research. His work has garnered attention for its potential applications in treating neurodegenerative diseases. He has successfully developed methods that could lead to breakthroughs in understanding and mitigating axonal degeneration.
Collaborations
Some of Craig A Press's notable coworkers include Aaron DiAntonio and Bradley R Miller. Their collaborative efforts contribute to advancing research in the field of axonal degeneration and related neurological studies.
Conclusion
Craig A Press is a prominent inventor whose work on axonal degeneration has the potential to impact the treatment of neurological disorders significantly. His innovative methods and compositions represent a valuable contribution to neuroscience research.